Cargando…

Efficacy of teriparatide compared with risedronate on FRAX(®)-defined major osteoporotic fractures: results of the VERO clinical trial

SUMMARY: FRAX(®) calculates the 10-year probability of major osteoporotic fractures (MOF), which are considered to have a greater clinical impact than other fractures. Our results suggest that, in postmenopausal women with severe osteoporosis, those treated with teriparatide had a 60% lower risk of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Body, J.-J., Marin, F., Kendler, D.L., Zerbini, C.A.F., López-Romero, P., Möricke, R., Casado, E., Fahrleitner-Pammer, A., Stepan, J.J., Lespessailles, E., Minisola, S., Geusens, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497508/ https://www.ncbi.nlm.nih.gov/pubmed/32474650 http://dx.doi.org/10.1007/s00198-020-05463-4

Ejemplares similares

Comparative Effects of Teriparatide and Risedronate in Glucocorticoid-Induced Osteoporosis in Men: 18-Month Results of the EuroGIOPs Trial
por: Glüer, Claus-C, et al.
Publicado: (2013)

Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX
por: Harvey, N. C., et al.
Publicado: (2015)

Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran
por: Ebadi Fard Azar, Amir Ali, et al.
Publicado: (2017)

Feasibility of FRAX for Prediction of Osteoporotic Vertebral Fractures in Korea
por: So, Gwang-Young, et al.
Publicado: (2012)

Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report
por: Fahrleitner-Pammer, A., et al.
Publicado: (2016)

Effects of teriparatide compared with risedronate in the treatment of osteoporosis: A meta-analysis of randomized controlled trials
por: Yang, Chengzhi, et al.
Publicado: (2020)

Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment
por: Geusens, Piet, et al.
Publicado: (2022)

Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model
por: Issayeva, S., et al.
Publicado: (2020)

Osteoporosis treatment in Austria—assessment of FRAX-based intervention thresholds for high and very high fracture risk
por: Dimai, Hans P., et al.
Publicado: (2022)

Lumbar spine bone mineral density and trabecular bone score-adjusted FRAX, but not FRAX without bone mineral density, identify subclinical carotid atherosclerosis
por: Pepe, J., et al.
Publicado: (2021)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Masud, Tahir, et al.
Publicado: (2009)

Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate
por: Yano, Tetsuo, et al.
Publicado: (2017)

High Alcohol Intake in Older Men and the Probability of Osteoporotic Fracture According to the FRAX Algorithm
por: Pasco, Julie A., et al.
Publicado: (2021)

Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study
por: Ljunggren, Östen, et al.
Publicado: (2013)

Assessment of Individual Fracture Risk: FRAX and Beyond
por: van den Bergh, Joop P. W., et al.
Publicado: (2010)

The Risk of Osteoporotic Fractures According to the FRAX Model in Korean Patients with Rheumatoid Arthritis
por: Lee, Jae Ho, et al.
Publicado: (2014)

Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model
por: Zakroyeva, Alla, et al.
Publicado: (2020)

Effectiveness of Teriparatide in Women Over 75 Years of Age with Severe Osteoporosis: 36-Month Results from the European Forsteo Observational Study (EFOS)
por: Walsh, J. Bernard, et al.
Publicado: (2012)

A new FRAX model for Brazil
por: Albergaria, B. H., et al.
Publicado: (2023)

Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study
por: Jakob, F, et al.
Publicado: (2012)

Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study
por: Jakob, F, et al.
Publicado: (2012)

Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)
por: Fahrleitner-Pammer, A., et al.
Publicado: (2010)

FRAX®: Prediction of Major Osteoporotic Fractures in Women from the General Population: The OPUS Study
por: Briot, Karine, et al.
Publicado: (2013)

Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance
por: Ke, Cheng‐hui, et al.
Publicado: (2021)

Nonsurgical Corrective Union of Osteoporotic Vertebral Fracture with Once-Weekly Teriparatide
por: Miyakoshi, Naohisa, et al.
Publicado: (2015)

The Effect of Postoperative Use of Teriparatide Reducing Screw Loosening in Osteoporotic Patients
por: Kim, Jae Wook, et al.
Publicado: (2018)

Cost‐Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate‐Alone Strategies in High‐Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide
por: Mori, Takahiro, et al.
Publicado: (2019)

Analysis of radiologic and clinical outcome in acute osteoporotic vertebral compression fracture: Single-agent teriparatide vs. teriparatide with subsequent vertebroplasty()
por: Jin, Yongjun
Publicado: (2023)

Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)
por: Langdahl, Bente L., et al.
Publicado: (2009)

Teriparatide for osteoporosis: importance of the full course
por: Lindsay, R., et al.
Publicado: (2016)

Assessment of osteoporotic fracture risk in urban Indian population using quantitative ultrasonography & FRAX tool
por: Vaishya, Raju, et al.
Publicado: (2017)

The Effect of FRAX on the Prediction of Osteoporotic Fractures in Urban Middle-aged and Elderly Healthy Chinese Adults
por: Wang, Jun, et al.
Publicado: (2017)

The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX® Algorithm
por: Klop, Corinne, et al.
Publicado: (2015)

Sustained anti-osteoporotic action of risedronate compared to anti-RANKL antibody following discontinuation in ovariectomized mice
por: Omiya, Toshinobu, et al.
Publicado: (2020)

Effects of teriparatide on cementless bipolar hemiarthroplasty in patients with osteoporotic femoral neck fractures
por: Huang, Tsan-Wen, et al.
Publicado: (2016)

Therapeutic Effect of Teriparatide for Osteoporotic Thoracolumbar Burst Fracture in Elderly Female Patients
por: Yu, Dongwoo, et al.
Publicado: (2020)

Ireland DXA-FRAX may differ significantly and substantially to Web-FRAX
por: Yang, Lan, et al.
Publicado: (2023)

Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
por: Minisola, Salvatore, et al.
Publicado: (2019)

FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort
por: Azagra, Rafael, et al.
Publicado: (2012)

Current Role and Application of Teriparatide in Fracture Healing of Osteoporotic Patients: A Systematic Review
por: Kim, Sang-Min, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7s0fq6er08k1lv25ie0hg2qtl4